Kingdon Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-100,000
Closed -$13.5M – 65
2020
Q3
$13.5M Buy
+100,000
New +$13.6M 1.52% 22
2017
Q3
– Sell
-299,400
Closed -$30.9M – 126
2017
Q2
$30.9M Buy
+299,400
New +$29.5M 2.12% 13
2016
Q1
– Sell
-450,000
Closed -$50.8M – 126
2015
Q4
$50.8M Buy
+450,000
New +$48.8M 2.47% 9
2015
Q3
– Sell
-435,000
Closed -$53.5M – 145
2015
Q2
$53.5M Buy
435,000
+60,000
+16% +$7.18M 2.09% 11
2015
Q1
$42.9M Sell
375,000
-375,000
-50% -$41.4M 1.82% 9
2014
Q4
$75.8M Buy
+750,000
New +$72.9M 3.3% 5
2014
Q3
– Sell
-525,000
Closed -$45M – 172
2014
Q2
$45M Buy
+525,000
New +$41.4M 1.73% 10
2014
Q1
– Sell
-300,000
Closed -$22.7M – 191
2013
Q4
$22.7M Buy
+300,000
New +$21.3M 1.04% 23
2013
Q3
– Sell
-300,000
Closed -$17.4M – 203
2013
Q2
$17.4M Buy
+300,000
New +$17.3M 1.03% 16

Other funds holding IBB